In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.
A third of patients who have taken the common psychiatric medication lithium for over ten years have developed "chronic renal failure" from the drug.
Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.
Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
Lithium appears to reduce libido and sexual function, and more research into the problem is needed.
Mixed-Methods study explores the experiences of antipsychotic discontinuation among service users.
Common second-generation antipsychotic medications are causing symptoms of obsessive-compulsive disorder to emerge in many people who previously only had schizophrenia symptoms, according to a...
Researchers examine how rapid discontinuation can mimic the relapse of mental health symptoms and confound psychiatric drug studies.
A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.
Patient Drug News advises avoiding use of the antidepressant Vortioxetine (also called Brintellix or Trintellix), because the most recent evidence from the FDA shows...
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...
A new study reported on in Medscape, examined risk factors for misuse of benzodiazepines (drugs such as Xanax, Ativan, and Klonopin). The researchers found that patients who had been prescribed the medication on an as-needed basis were more likely to end up abusing it than those who had been prescribed a standing dose.
Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.
Common scientific beliefs about serotonin levels in depression and how antidepressants act on the brain appear to be completely backwards.
Researchers interviewed people who were given medical advice to discontinue antidepressants.
Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.
New research suggests that clinicians should exercise caution prescribing SNRIs as first-line treatment for mood and anxiety disorders.
A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.
Psychiatrist and psychologist outline pharmacological and psychotherapeutic strategies for discontinuing antidepressants.
Greater cumulative doses of drugs that are anticholinergic or block the neurotransmitter acetylcholine are associated with significant increases in dementia and Alzheimer's.